Hailan Liu, PA-C, PhD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111


Advanced Practice Clinician

​Physician Assistant

Treatment Focus

Survivorship planning for patients with melanoma.

Treatment Philosophy

Where you start your cancer care matters!
I am honored to be part of the surgical oncology team providing care for patients with skin cancer (including melanoma, merkel cell carcinoma, advance squamous cell carcinoma), sarcomas, and gastrointestinal cancers. I treasure my relationship with my patients and thrive to provide the very best care for patients who undergo surgery and throughout the rest of their cancer journey. I follow early stage melanoma patients as well as melanoma survivors in the survivor clinic.

Education and Training

Educational Background

  • MS,Physician Assistant Studies, Indiana University, Indianapolis, IN, 2015
  • PhD, Pharmacology, Indiana University School of Medicine, Indianapolis, IN, 2008
  • BS, Biochemistry, Nanjing University, China, 1998


  • Physician Assistant Certified


  • Member, American Society of Clinical Oncology

Honors & Awards

  • PA National Honor Society Pi Alpha Inductee, 2015
  • KK Chen Award, Department of Pharmacology, Indiana University School of Medicine, 2008
Research Profile

Research Interests

Cancer Survivorship


Selected Publications

Liu, Y.; Liu, H.; Han, B.; Zhang, J.T. Identification of 14-3-3- as a contributor to drug resistance in human breast cancer cells using functional proteomics analysis.  Cancer Res.66(6):3248-3255,2006

Liu, H., Liu, Y. and Zhang, J.T. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther. 7(2):263-70,2008

Liu, H., Liu, J., Wu, X and Zhang, J.T. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Bio. 1(1): 69–89, 2010

Yang, Y., Liu, H., et al and Zhang, J.T. Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. Int J Biochem Mol Biol. 2(1): 89–98, 2011

Liu H., Wu, X. Dong, Z., et al and Zhang, J. T. Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production. J Lipid Res, 54 (3): 776-85, 2013

Gu D., Liu H., Su G., et al and Xie J. Combining Hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther. 12(6): 1038-48, 2013

Fan, Q., Gu, D., Liu, H. et al and Xie, J. Defective TGF-β in bone marrow-derived cell prevents Hedgehog-induced skin tumors. Cancer Res. 74(2): 471-83, 2014

Renzetti M, Soliman I, Wu H, Luo B, Liu H, Olszansi A, Movva S, Lango M, Reddy S. Zih F. Farma JM. Evaluation of Molecular Profile in High Risk Class 2 MelanomaDx 

Connect with Fox Chase